Suchergebnisse - "Domchek, Susan M"

PubPharm (85)

1

Patient-Reported Outcomes in OlympiA : A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Ganz, P. | Bandos, H. | Španić, T. | +43

2

The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Brown, T. | Yablonovitch, A. | Till, J. | +11

CommentIn: Clin Cancer Res. 2023 Dec 15;29(24):5005-5007. - PMID 37787975

3

Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival

enthalten in: JAMA network open | 2023

von Boursi, B. | Wileyto, E. | Mamtani, R. | +4

4

Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers

enthalten in: JCO precision oncology | 2023

von Wineland, D. | Le, A. | Hausler, R. | +18

5

Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer : Subgroup analyses from the phase III OlympiAD trial

enthalten in: International journal of cancer | 2023

von Senkus, E. | Delaloge, S. | Domchek, S. | +8

6

Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor-Resistant Homologous Recombination-Deficient Ovarian Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Wethington, S. | Shah, P. | Martin, L. | +16

7

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

enthalten in: British journal of cancer | 2023

von O'Mahony, D. | Ramus, S. | Southey, M. | +96

8

Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles

enthalten in: Nature communications | 2023

von Elias, K. | Smyczynska, U. | Stawiski, K. | +14

9

Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Lau-Min, K. | McCarthy, A. | Nathanson, K. | +1

CommentIn: J Natl Compr Canc Netw. 2023 Apr;21(4):430-432. - PMID 37015334

10

Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Yadav, S. | Boddicker, N. | Na, J. | +33

1
2
3
4
5
6
7
8
9
Nächster »
[9]